Abstract
Bronchiolitis manifests as a variety of histological features that explain the complex clinical profiles and imaging aspects. In the period between January 2011 and June 2015, patients with a cryobiopsy diagnosis of bronchiolitis were retrospectively retrieved from the database of our institution. Clinical profiles, imaging features and histologic diagnoses were analysed to identify the role of cryobiopsy in the diagnostic process. Twenty-three patients with a multidisciplinary diagnosis of small airway disease were retrieved (14 females, 9 males; age range 31–74 years old; mean age 54.2 years old). The final MDT diagnoses were post-infectious bronchiolitis (n = 5), constrictive bronchiolitis (n = 3), DIPNECH (n = 1), idiopathic follicular bronchiolitis (n = 3), Sjogren’s disease (n = 1), GLILD (n = 1), smoking-related interstitial lung disease (n = 6), sarcoid with granulomatous bronchiolar disorder (n = 1), and subacute hypersensitivity pneumonitis (n = 2). Complications reported after the cryobiopsy procedure consisted of two cases of pneumothorax soon after the biopsy (8.7%), which were successfully managed with the insertion of a chest tube. Transbronchial cryobiopsy represents a robust and mini-invasive method in the characterization of small airway diseases, allowing a low percentage of complications and good diagnostic confidence.
Similar content being viewed by others
Introduction
Bronchioles are non-cartilaginous small conducting airways with an internal diameter of approximately 2 mm1. Several classification schemes for bronchiolitis have been presented in the literature. In recent years, Ryu et al. 2 differentiated bronchiolar diseases into three groups: primary bronchiolar disorders, interstitial lung disease with prominent bronchiolar involvement and bronchiolar involvement in large airway disease.
The first category includes those entities in which bronchiolar disorder is the predominant abnormality, such as constrictive bronchiolitis, acute bronchiolitis, diffuse panbronchiolitis, respiratory bronchiolitis, mineral dust airway disease, and follicular bronchiolitis.
The second group represents all parenchymal lung diseases that can affect bronchioles to varying degrees, such as hypersensitivity pneumonitis, RB-ILD and DIP.
The third group represents the bronchiolar involvement of large airway disease, as in bronchiectasis, COPD or asthma.
There are several causes of bronchiolar diseases2: infections, inhalation of toxic agents (toxins, dusts or gases), drug reactions, collagen vascular disease, graft versus host disease (GVHD), lung transplantation, chronic occult aspiration, inflammatory bowel disease (IBD), and constrictive bronchiolitis associated with paraneoplastic autoimmune multi-organ syndrome3,4,5,6.
Even a preneoplastic disorder, diffuse idiopathic neuroendocrine cell hyperplasia with constrictive bronchiolitis (DIPNEH), has been included in this category8,9.
In a minority of cases, the aetiology of bronchiolar disorders remains unknown10,11,12,13,14,15,16,17,18,19,20,21,22.
A fundamental step for diagnosis and classification is the computed tomography (CT) scan23,24,25,26. The secondary lobule is the smallest unit that can be imaged; it has a polygonal shape, measuring approximately 2 cm in size. Inside the secondary lobules, there are 6 to 8 primary lobules with a central terminal bronchiole, with further subdivision into pyramidal acini, whose apices are located halfway between the centre of the secondary lobule and the interlobular septa. In this anatomical context, radiological signs of bronchiolar disorders can be directly identified (direct signs) or indirectly inferred (indirect signs). Therefore, ill-defined ground-glass centrilobular nodules are related to filling of the centrilobular space; tree-in bud patterns are related to mucoid impaction of the terminal bronchioles, and mosaic attenuation and air trapping in the expiratory scans are related to the obstruction of terminal bronchioles and secondary vasospasm27,28,29,30,31,32,33,34,35,36.
Even though surgical lung biopsy is still considered the gold standard for diagnosis, transbronchial cryobiopsy (TBLC) is an emerging tool that is being considered as a valid alternative, as it has already been demonstrated for fibrosing and non-fibrosing ILDs37,38,39,40,41,42,43,44,45,46,47,48,49,50. The aim of this article was to evaluate the role of cryobiopsy in the diagnostic work-up of bronchiolar disorders.
Methods
Patients
The study was approved by the USL Romagna-Ethical Committee as part of the study on cryobiopsy feasibility: prior to the procedure, written informed consent was obtained from all patients. Moreover, all methods were performed in accordance with the relevant guidelines and regulations of the journal.
We retrospectively retrieved from the database of our institution patients who underwent transbronchial cryobiopsy and who subsequently received a multidisciplinary diagnosis of bronchiolitis between January 2011 and June 2015.
The inclusion criteria were a histologic diagnosis through cryobiopsy and the availability of CT images.
Radiological assessment
A CT scan (16-slice Light Speed scanner GE Medical Systems, Milwaukee, WI) was performed at least one month before biopsy in all cases. The parameters of acquisition were as follows: 1.5-mm slice thickness with 1-mm collimation and 1-mm reconstruction. The expiratory scan was performed in each patient for the entire lung at 10–20 mm intervals. All images were reviewed at window settings optimized for the lung parenchyma (width, 1,500–1,600 HU; level, 2,500 to 2,600 HU).
Findings were recorded according to the Fleischner Nomenclature51 as follows: ill-defined centrilobular nodules, tree-in-bud patterns, mosaic attenuation, and air trapping. Furthermore, ancillary and incidental findings were recorded.
Biopsy procedure
A flexible cryoprobe measuring 90 cm in length and 1.9 mm in diameter was used (ERBE, Germany). The patients were deeply sedated with intravenous propofol and remifentanil and, while spontaneously breathing, intubated with a rigid tracheoscope. The biopsies were obtained under fluoroscopic guidance using the flexible bronchoscope inserted through the rigid tube into the selected bronchus. A distance of approximately 10 mm from the thoracic wall was considered optimal and always assessed by fluoroscopy. Once brought into position, the probe was cooled for approximately 7–8 s; then, it was retracted with the frozen lung tissue attached to the tip of the probe. The frozen specimen was thawed in saline and then transferred to formalin for fixation. Four specimens from at least two different segments from the same lobe were obtained.
A Fogarty balloon was prophylactically placed in the segmental bronchus near the biopsy site and routinely inflated after sampling to minimize the consequences of haemorrhage. The choice of the site and side of biopsy was decided upon before the procedure on the basis of the distribution of CT findings.
Histologic analysis
Haematoxylin–eosin–stained slides were reviewed, and specific stains were obtained when deemed useful. Histologic diagnosis of bronchiolitis was based on the above-mentioned classifications2,3. Specimens were reviewed by two lung pathologists (AD and VP).
Results
Patients
Twenty-three patients with an MDT diagnosis of bronchiolar disease (9 males, 14 females; age range 37–74 years old; mean age 54.2) were collected.
After the procedure, two subjects (8.7%) developed pneumothorax, which was successfully managed with chest tube insertion. No complications were reported.
The histologic categories identified were grouped according to the Ryu classification into primary bronchiolitis and interstitial lung diseases with a prominent bronchiolar component. No cases of bronchiolar disorders associated with large airway disease underwent a cryobiopsy procedure.
In the primary bronchiolitis section, ten patients showed cellular bronchiolitis (5 cases of post-infectious bronchiolitis and 5 cases of follicular bronchiolitis), and three cases showed constrictive bronchiolitis (2 cases of cryptogenic bronchiolitis and 1 case of DIPNECH).
In the group of ILDs with prominent bronchiolar components, we recorded 6 cases of RB-ILD, 1 case of granulomatous bronchiolitis and 2 cases of hypersensitivity pneumonitis.
Age, sex, clinical symptoms, and smoking status are summarized in Tables 1–2. The imaging findings are summarized in Table 3.
Primary Bronchiolar disorders
-
1.
Cellular Bronchiolitis
-
a.
Infectious Bronchiolitis: five patients were recorded (4 females, 1 male). Cultures of the bronchoalveolar lavage fluid were positive for Haemophilus influenza in 3 patients, Nocardia abscess in one case and Mycobacterium avium-intracellular complex in one case. Samples were characterized by the presence of debris, neutrophil micro-abscesses and submucosal oedema.
In all cases, CT scans showed a prominent tree-in-bud pattern related to mucoid impaction of the terminal bronchioles. Mild concomitant mosaic attenuation was observed.
All the patients received antibiotic therapy after MDT diagnosis.
-
b.
Follicular Bronchiolitis: five patients were recorded (4 females, 1 male). Histologically, follicular bronchiolitis was characterized by the presence of lymphoid follicles with germinal centres around the small airways. In all cases, the microbiological investigation results were negative.
CT scan features included the following: ill-defined nodules in one case, ground-glass attenuation and nodules with halo signs in one case, tree-in-bud patterns in two cases, and mosaic attenuation in one case.
The final MDT diagnoses were as follows: Sjogren’s syndrome in one case, an idiopathic form in three cases (Fig. 1), and GLILD in one case affected by common variable immunodeficiency.
Treatment consisted of steroids in cases of an idiopathic form and rituximab, azathioprine and immunoglobulins in the case of GLILD.
-
2.
Constrictive Bronchiolitis
-
a.
Three patients: the CT scan findings were tree-in-bud patterns in two cases and mosaic attenuation and air trapping in one case. Treatment consisted of antibiotics and immunomodulators for the cryptogenic forms.
-
b.
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIP-NECH): one case. The patient presented with typical CT findings: mosaic attenuation and air trapping as well as small scattered nodules (Fig. 2). Treatment consisted of follow-up.
ILD with a prominent bronchiolar component
-
a.
Respiratory Bronchiolitis-ILD (RB-ILD) six patients (2 females, 4 males); all the subjects were current smokers. CT scans showed ill-defined ground-glass nodules in five cases representing RB-ILD and diffuse ground-glass attenuation in one case mostly related to desquamative interstitial pneumonia (DIP). This patient had significant eosinophilia in the bronchoalveolar lavage (BAL) fluid, and his final diagnosis was DIP.
-
b.
Hypersensitivity Pneumonitis (HP) In two patients, the final diagnosis was chronic hypersensitivity pneumonitis. In one case, a positive history of exposure to birds and positive serum precipitins were confirmed. In the second subject, the final diagnosis was subacute hypersensitivity pneumonitis related to sulphasalazine treatment. CT scan aspects were mosaic attenuation and centrilobular nodules. Treatment consisted of drug suspension.
-
c.
Granulomatous In one case, a peculiar clinical background of sarcoidosis and Evan's syndrome was identified. CT scans were characterized by ill-defined nodules. Histology showed small non-necrotizing granulomas around the small airways. The final diagnosis was granulomatous bronchiolitis in concomitant sarcoidosis, and treatment consisted of steroids and rituximab.
Discussion
Small airway disease, or bronchiolitis, is a broad term encompassing numerous diseases that cause bronchiolar inflammation or fibrosis. It generally refers to airways measuring less than 2 mm in diameter, lacking the cartilaginous component in the wall of the airway until the alveolar ducts52,53,53. This heterogeneous group usually manifests with non-specific respiratory symptoms such as cough, dyspnoea and fever. Imaging can show a variety of findings, depending on the physiopathology present in the background.
As the smallest unit imaged on CT scans is the secondary lobule, the direct signs of bronchiolitis include centrilobular nodules or centrilobular ground-glass opacities and a tree-in-bud pattern typically reflecting a cellular or inflammatory form of bronchiolitis.
Indirect signs are air trapping and mosaic attenuation. Air trapping results from the partial outflow obstruction of the small airways. This can be related to a collapse of the bronchioles during expiration. Air trapping is characterized by areas of low attenuation of the pulmonary density and is a sign of constrictive bronchiolitis52.
Mosaic attenuation can be attributed to vascular causes as well as to bronchiolitis. In small airway diseases, such as bronchiolitis, a vasoconstrictive reflex can be observed, resulting in hypoperfusion53.
Diagnosis requires the combination of clinical, radiological and histological data54,55,56,57,58,59,60.
In our cohort of patients, a tree-in-bud pattern, as a direct sign of bronchiolar mucous impaction, was mostly represented in the group of infectious bronchiolitis (5 cases), follicular bronchiolitis (2 out of 5) and constrictive bronchiolitis (2 out of 3).
Ill-defined centrilobular nodules were the most frequent in the group of RB-ILD cases (5 out of 6) and were seen in a case of HP.
Mosaic attenuation and air trapping were mostly represented in the group of constrictive bronchiolitis (1 case), DIPNECH (1 case) and bronchiolitis in HP (1 case).
Traditional transbronchial biopsy has been recently investigated for its accuracy in the diagnosis of interstitial lung disease and has demonstrated an accurate diagnosis in only 20% to 30% of cases. Therefore, a surgical lung biopsy is still considered crucial to provide large and diagnostic specimens60.
In recent years, transbronchial cryobiopsy has shown a high diagnostic yield in diffuse parenchymal lung disorders in contrast to conventional forceps biopsy with a diagnostic accuracy closer to that of surgical lung biopsy61. Recently, Colella et al.62 emphasized the diagnostic value of TBLC in evaluating subsets of asthmatic patients. They, in fact, performed cryobiopsy in three patients affected by asthma, obtaining useful information for the pathophysiology of the disease. With TBLC samples, the authors obtained information about bronchiolar changes, particularly goblet metaplasia and eosinophilic infiltration of mucosa and submucosa of bronchioles and nodular lymphoid inflammation.
Our investigation sought to evaluate whether TBLC combined with CT interpretation and multidisciplinary discussion could be a promising and safe tool comparable and an alternative to diagnosis with surgical biopsy, as recently stated by Hetzel and co-workers63.
Based on these data, the histological information from cryobiopsy specimens allowed an appropriate diagnosis of cellular, respiratory, and follicular bronchiolitis, as well as constrictive bronchiolitis (Fig. 3). Interestingly, cryobiopsy has been shown to be a valid tool in the diagnosis of pre-neoplastic conditions, such as DIPNECH sampling of small tumourlets and bronchiolar fibrosis.
In detailed cryobiopsy, samples are large enough for the identification of terminal and respiratory bronchioles and for retrieving a conspicuous amount of alveolar tissue. The literature indicates that the pneumothorax rate varies from less than 1% to almost 30%55.
Pneumothorax has been recorded as the main complication observed, but it was observed in a minority of cases (8.6%). Based on the reported data63, TBCB should be performed by interventional pulmonologists appropriately trained in a centre familiar with advanced therapeutic bronchoscopic procedures (management of massive haemoptysis and tension pneumothorax). There are two major limitations in this study that could be addressed in future research.
First, the analysis focused on a relatively small sample of patients; second, it was based on a retrospective observational analysis, which likely resulted in the loss of some indeterminate cases. Further prospective studies with a larger cohort of patients are recommended.
Conclusion
TBCB is a promising technique that substantially expands the pulmonary armamentarium in the diagnosis of bronchiolitis.
References
Ryu, J. H., Myers, J. L. & Swensen, S. J. Bronchiolar disorders. Am. J. Respir. Crit. Care Med 168, 1277–1292 (2003).
Ryu, J. H. Classification and approach to bronchiolar diseases. Curr. Opin. Pulm. Med. 12, 145–151 (2006).
Ravaglia, C., Poletti, V. Recent advances in the management of acute bronchiolitis. F1000Prime Rep. 6, 103 (2014)
Miller, R. R., Muller, N. L. & Thurlbeck, W. M. Diffuse diseases of the lungs. In Principles and practice of surgical pathology and cytopathology Vol. 2 (eds Silverberg, S. G. et al.) 1152–1154 (Churgill Livingstone, London, 1997).
Maldonado, F., Pittelkow, M. R. & Ryu, J. H. constrictive bronchiolitis associated with paraneoplastic autoimmune multi-organ syndrome. Respirology 14, 129–133 (2009).
Cordier, J. F., Cottin, V., Lazor, R. & Thivolet-Béjui, F. Many faces of Bronchiolitis and organizing pneumonia. Semin. Respir. Crit. Care Med. 37, 421–440 (2016).
Poletti, V., Chilosi, M. & Zompatori, M. Bronchiolitis. Prog. Respir. Res. 36, 292–306 (2007).
Mengoli, M. C., Rossi, G., Cavazza, A. & Colby, T. V. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNEH) syndrome and carcinoid tumors with/without NECH: a clinicopathologic, radiologic, and immunomolecular comparison study. Am. J. Surg. Pathol. 42, 646–655 (2018).
Pietrangeli, V., Piciucchi, S., Tomassetti, S. & Poletti, V. Diffuse neuroendocrine hyperplasia with obliterative bronchiolitis and usual interstitial pneumonia: an unusual "Headcheese Pattern" with nodules. Lung (2015).
Kindt, G. G., Weiland, J. E., Davis, W. B. & Dorinsky, P. M. Bronchiolitis in adults. A reversible cause of airway obstruction associated with airway neutrophils and neutrophils products. Am. Rev. Respir. Dis. 140, 483 (1989).
Macklem, P. T., Thurlbeck, W. M. & Fraser, R. O. Chronic obstructive disease of small airways. Ann. Intern. Med. 74, 167 (1971).
Poletti, V., Casoni, G., Chilosi, M. & Zompatori, M. Diffuse panbronchiolitis. Eur. Respir. J. 28, 862–871 (2006).
Katzenstein, A. L. & Miscellaneous, I. I. “Non-neoplastic lung disease. Miscellaneous II”. Small airways disease Saunders Elsevier Fourth edition, 456–464 (2006)
Hogg, J. C. Bronchiolitis in chronic obstructive pulmonary disease. Proc. Am. Thorax Soc. 3, 489–493 (2006).
Wohl, M. E. & Chernick, V. State of the art: bronchiolitis. Am. Rev. Respir. Dis. 118, 759–781 (1978).
Henderson, F. W. et al. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J. Pediatr. 95, 183–190 (1979).
Penn, C. C. & Liu, C. Bronchiolitis following infection in adults and children. Clin. Chest Med. 14, 645–654 (1993).
Larranaga, C., Kajon, A. & Villagra, E. Adenovirus surveillance on children hospitalized for acute lower respiratory infections in Chile (1988–1996). J. Med. Virol. 60, 342–346 (2000).
Jinho, Y. Postinfectious bronchiolitis obliterans in children: lessons from bronchiolitis obliterans after lung transplantation and hematopoietic stem cell transplantation. Korean J. Pediatr. 58, 459 (2015).
Andersen, P. Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses. Thorax 53, 302–307 (1998).
Leong, M. A., Nachajon, R., Ruchelli, E. & Allen, J. L. Bronchitis obliterans due to Mycoplasma pneumoniae. Pediatr. Pulmonol. 23, 375–381 (1997).
Jensen, S. P., Lynch, D. A., Brown, K. K., Wenzel, S. E. & Newell, J. D. High-resolution CT features of severe asthma and bronchiolitis obliterans. Clin. Radiol. 57, 1078–1085 (2002).
Arakawa, H. & Webb, W. R. Air trapping on expiratory high-resolution CT scans in the absence of inspiratory scan abnormalities: correlation with pulmonary function tests and differential diagnosis. AJR Am. J. Roentgenol. 170, 1349–1353 (1998).
Webb, W. R. High-resolution computed tomography of obstructive lung disease. Radiol. Clin. North Am. 32, 745–757 (1994).
Teel, G. S., Engeler, C. E., Tashijian, J. H. & duCret, R. P. Imaging of small airways disease. Radiographics 16, 27–41 (1996).
Daxbock, F., Brunner, G., Popper, H. & Wenish, C. A case of lung transplantation following Mycoplasma pneumoniae infection. Eur. J. Clin. Microbiol. Infect. Dis. 21, 318–322 (2002).
Colom, A. J., Teper, A. M., Vollmer, W. M. & Diette, D. B. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax 61, 503–506 (2006).
Collins, J., Blankenbaker, D. & Stern, E. J. CT patterns of bronchiolar disease: what is “tree-in-bud”?. AJR 71, 365–370 (1998).
Hansell, D. M., Rubens, M. B., Padley, S. P. & Wells, A. U. Obliterative bronchiolitis: individual CT signs of small airways disease and functional correlation. Radiology 203, 721–726 (1997).
Muller, N. L. Advances in imaging. Eur. Respirol. J. 18, 867–871 (2001).
Devakonda, A., Raoof, S., Sung, A. & Naidich, D. Bronchiolar disorders: a clinico-radiological diagnostic algorithm. Chest 137, 938–951 (2010).
Hirschmann, J. V., Sudhakar, N., Pipayath, J. & Godwin, D. Hypersensitivity pneumonitis: A historical, clinical and radiologic review. RadioGraphics 29, 1921–1938 (2009).
Pipavath, S. J., Lynch, D. A., Cool, C., Brown, K. K. & Newell, J. D. Radiologic andpathologic features of bronchiolitis. AJR Am. J. Roentgenol. 185, 354–363 (2005).
Howling, S. J., Hansell, D. M., Wells, A. U. & Muller, N. L. Follicular bronchiolitis: thin section CT and histologic findings. Radiology 212, 637–642 (1999).
Yousem, S. A., Colby, T. V. & Carrington, C. B. Follicular bronchitis/ bronchiolitis. Hum. Pathol. 16, 700–706 (1985).
Eun-Young, K. et al. Bronchiolitis: classification, computed tomographic and histopathologic features, and radiologic approach. J. Comput. Assist Tomogr. 33, 32–41 (2009).
Stern, E. J., Swensen, S. J., Hartman, T. E. & Frank, M. S. CT mosaic pattern of lung attenuation: distinguishing different causes. Am. J. Roentgenol. 165, 813–816 (1995).
Epler, G. R. Bronchiolitis obliterans organizing pneumonia: definition and clinical features. Chest 102, 2S-6S (1992).
Couture, C. & Colby, T. V. Histopathology of bronchiolar disorders. Semin. Respir. Crit. Care Med. 24(5), 489–498 (2003).
Portnoy, J. et al. Respiratory bronchiolitis-interstitial lung disease: long term outcome. Chest 131, 664–671 (2007).
Anders, G. T., Johnson, J. E., Bush, B. A. & Mattews, J. I. Transbronchial biopsy without fluoroscopy, a seven year perspective. Chest 94, 557 (1988).
Anderson, H. A. Transbronchial lung biopsy for diffuse pulmonary diseases. Result in 939 patients. Chest 73, 734 (1978).
Kreider, M. E. et al. Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. Ann. Thorac. Surg. 83, 1140–1145 (2007).
Park, J. S. et al. Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J. Comput. Assist. Tomogr. 26, 13–20 (2002).
Babiak, A. et al. Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration 78, 203–208 (2009).
Clark, R. A., Gray, P. B., Townshend, R. H. & Howard, P. Transbronchial lung biopsy: a review of 85 cases. Thorax 32, 546 (1977).
Pajares, V., Puzo, C., Castillo, D. & Torrego, A. Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial. Respirology 19, 900–916 (2014).
Ravaglia, C., Bonifazi, M., Athol, U. W., Tomassetti, S. & Poletti, V. Safety and diagnostic yield of transbronchial lung cryobiopsy in diffuse parenchymal lung diseases: a comparative study versus video-assisted thoracoscopic lung biopsy and a systemic review of the literature. Respiration 2016(91), 215–227 (2016).
Poletti, V., Patelli, M., Ferracini, R., Simonetti, M. & Spiga, L. Transbronchial lung biopsy in infiltrative lung disease: the importance of the pathologic approach. Sarcoidosis 5, 43–50 (1998).
Hansell, D. M. et al. Fleischner society: glossary of terms for thoracic imaging. Radiology 246, 697–722 (2008).
Berniker, A. V. & Henry, T. S. Imaging of small airways diseases. Radiol. Clin. North Am. 54(6), 1165–1181 (2016).
Edwards, R. M., Kicska, G., Schmidt, R. & Pipavath, S. N. Imaging of small airways and emphysema. Clin. Chest. Med. 36(2), 335–348 (2015).
Poletti V, Casoni G, Zompatari M, Carloni A & Chilosi M. European respiratory monograph orphan lung diseases: 92–111 (2011)
Sergej Griff, Nicolas Schonfeld & Wurps H. Diagnostic yield of transbronchial cryobiopsy in non-neoplastic lung disease: retrospective case series. BMC Pulm Med. 14:171 (2014)
Casoni, G., Tomassetti, S., Cavazza, A. & Poletti, V. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS ONE 9, e86716 (2014).
Colby, T. V. Bronchiolitis: pathologic considerations. Am. J. Clin. Pathol. 109, 101–109 (1998).
Myers, J. & Colby, T. Pathological manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin. Chest Med. 14, 611–622 (1993).
Visscher, D. W. & Myers, J. L. Bronchiolitis- pathologist’s perspective. Proc. Am. Thorac. Soc. 3, 41–47 (2006).
Sheth, J. S., Belperio, J. A., Fishbein, M. C. & Flaherty, K. R. Utility of transbronchial vs surgical lung biopsy in the diagnosis of suspected fibrotic interstitial lung disease. Chest 151, 389–399 (2017).
Kropski JA, Pritchett JM, Mason WR, Sivarajah L, Gleaves LA, Johson JE, & Rickman OB. Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung disease. PLoS One 8 (2013)
Ravaglia, C., Wells, A. U., Tomassetti, S. & Poletti, V. Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients. Pulm. Med. 19, 16 (2019).
Colella, S., Ravaglia, C., Massaccesi, C. & Poletti, V. Does transbronchial lung cryobiopsy give useful information in asthmatic patients?. Multidiscip. Respir. Med. 14, 12 (2019).
Hetzel, J. et al. transbronchial cryobiopsies for the diagnosis of diffuse parenchymal lung diseases: expert statement from the cryobiopsy working group on safety and utility and a call for standardization of the procedure. Respiration 95, 188–200 (2018).
Author information
Authors and Affiliations
Contributions
S.S.A.S, S.P., and V.P.: wrote the manuscript. S.T., C.R., A.D., and V.P.: collected cases and contributed to writing the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sirol Aflah Syazatul, S., Piciucchi, S., Tomassetti, S. et al. Cryobiopsy in the diagnosis of bronchiolitis: a retrospective analysis of twenty-three consecutive patients. Sci Rep 10, 10906 (2020). https://doi.org/10.1038/s41598-020-67938-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-020-67938-y
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.